Swiss Pharma Group Helsinn seals an alliance with Japanese company Chugai by granting exclusive distribution & licensing rights to commercialize its innovative phase III ghrelin receptor agonist in Germany, France, Benelux, UK and Ireland.
![2013-11-12--Helsinn Chugai anam agreement.pdf 2013-11-12--Helsinn Chugai anam agreement.pdf](/files/archives/p_2013-11-12--Helsinn Chugai anam agreement.jpg)
Swiss Pharma Group Helsinn seals an alliance with Japanese company Chugai by granting exclusive distribution & licensing rights to commercialize its innovative phase III ghrelin receptor agonist in Germany, France, Benelux, UK and Ireland.
Linkedin